The emergence of non-invasive bone stimulators, like pulse electromagnetic field (PEMF) stimulators, has increased the demand of spine bone stimulators. These devices are most commonly used as they result in low complication rates.
Global Spine Bone Stimulators Market was valued at $562 million in 2015, and is expected to reach $724 million by 2022, supported by a CAGR of 3.6% during the forecast period 2014 – 2022. Bone stimulators are used to enhance the bone’s healing process, which is crucial for spinal fusion procedure. A bone stimulator, may be internal or external, is a small device that delivers low-voltage electrical currents directly to the spinal area where bone growth (spine fusion) is about to occur. Typically, these devices are worn after spine fusion. Factors such as increase in geriatric population and rise in incidence of spinal disorders boost the market growth. However, advent of bone growth stimulating drugs, fixation instrumentation during fusion and non-union fractures, and high initial cost of these devices are expected to impede this market growth.
Spine bone stimulators and spinal instrumentation (plates, rods, and screws) and bone grafts are used during a spinal fusion surgery to enhance the bones healing process. These stimulators send low-level electrical signals to the fusion site, in turn activating the body’s natural bone healing process, which gets impaired in at-risk patients, preventing delayed unions or non-union of the spine fractures.
Get the PDF brochure of this market insight@ https://www.alliedmarketresearch.com/request-sample/1953
Increase in geriatric population and rise in incidence of osteoporosis and arthritis boost the market growth. However, advent of bone growth-stimulating drugs, fixation instrumentation during fusion and non-union fractures, and high initial cost of these devices are expected to impede the market growth. Non-invasive spine bone stimulators were the highest revenue-generating segment, accounting for more than two-thirds of the spine bone stimulators market.
The key players operating in the spine bone stimulators market focus on expanding their business operations in emerging countries with new product launches as a preferred strategy. The major companies profiled in the report include Aetna, Inc., Bioventus LLC, DJO Global, Inc., elizur Corporation, IGEA S.p.A., Medtronic plc, Orchid Medical, Inc., Orthofix International N.V., Ossatec Benelux B.V., Smith & Nephew plc, Verve Consulting Inc., and Zimmer Biomet Holdings, Inc.
Do Purchase Inquiry@ https://www.alliedmarketresearch.com/purchase-enquiry/1953
North America accounted for the major share of revenue in 2015, and is expected to maintain its dominance throughout the forecast period. However, Asia-Pacific is projected to be the fastest growing region, registering a CAGR of 4.5%. Improvement in healthcare infrastructure and increase in expenditure in emerging markets (such as India and China) to overcome the unmet medical needs in these countries have supplemented the market growth.